NCT07064538Active, not recruiting
Effects of Neuralli® MP on Self-Defined Outcomes in Adults With Autistic Traits
A Mixed-Methods Open-Label Trial Evaluating the Effects of Neuralli® MP on Self-Defined Outcomes in Adults With Autistic Traits
Source: ClinicalTrials.gov · Last updated 2 Jun 2026
Brief summary (registry, in English)
To evaluate the efficacy of Neuralli® MP in improving participant-defined outcomes in adults with autistic traits.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 11 Jul 2025
- Start date
- 19 Aug 2025
- Primary completion date
- 30 Apr 2026
- Lead sponsor
- Mackay Memorial Hospital
- Diseases
- Autism
- NCT number
- NCT07064538
What you commit to
- Study type: Interventional
- Planned participants: 15
- From 19 Aug 2025 to the primary completion date, 30 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participants currently receiving antibiotic treatment are also excluded.
- Ineligibility determined by PI, e.g. the individual starts any new medication or therapy, especially related to their autism, during this time.
Other illness
- Individuals with a known allergy to dairy products.
Other
- Those who have taken antibiotics or probiotic products in powder, capsule or tablet form within the past month are excluded.
- Individuals with immunodeficiency or compromised immune function.
- Individuals diagnosed with small intestinal bacterial overgrowth (SIBO)
Who the study is looking for
- Participants aged between 18 and 50 who exhibit autistic traits
- Those who have the willingness and ability to work but have not yet been able to enter a sheltered workshop at the Kanner Foundation
- The subjects, primary caregivers and institution staff are willing to participate in the study, and the primary caregivers and institution staff are willing to fill out the questionnaire and accept the interview
Age in the registry: 18 years to 50 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| MacKay Memorial Hospital Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.